MYC and cancer: The CDK7 inhibitor THZ1 and BRD4 inhibitor JQ1 can efficiently target MYC driven transcriptional amplification in other types of cancers, here we studied the potential role of THZ1 and JQ1 in regulation of ostesosarcoma.